Uniquity Bio is a clinical-stage biotechnology company committed to putting science and patients first. We exist to develop transformative new medicines for immune-mediated diseases, and we’re looking for bright-minded professionals driven by a desire to advance science and make a difference for people in need. Our lead asset, solrikitug, is a highly-potent TSLP inhibitor now in Phase 2 clinical trials for asthma, chronic obstructive pulmonary disorder (COPD), and eosinophilic esophagitis (EoE) indications. Join us in building an organization where people and science thrive together. You’ll have the opportunity to make a meaningful impact while working alongside a talented, agile team in an environment where ideas move quickly, colleagues are trusted, and quality remains a cornerstone. The Vice President of Program Management drives the strategic and operational execution of the company’s late-stage (Phase 2 and Phase 3) development programs. This position will report to the CEO and is a key member of the leadership team. This individual will drive integrated program strategy, execution and decision making partnering closely with cross-functional leaders to ensure clinical and regulatory success, and deliver critical value inflection points in a lean, fast-paced biotech environment. This role requires a highly experienced, hands-on leader with deep expertise in late-stage clinical development, who can successfully navigate complexity, manage cross functional relationships, and prepare programs for potential registration and commercialization.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior